Category: News

YO Sperm Motility Testing and Counting at Home

We’ve already seen products that offer men the ability to do sperm counts in the privacy of home. Yet, sperm count is only one indicator of healthy fertility. Whether sperm are lively and energetic is another important parameter. Medical Electronic Systems, a well known name in laboratory equipment for sperm quality analysis, is about to (Read more...)

Soft Artificial Muscles Built from Electroactive Yarn

Powered exoskeletons and other assistive devices tend to be clunky, noisy, and consist of rigid parts that can be heavy and uncomfortable to wear. Scientists at Linköping University and University of Borås in Sweden have developed a new way of powering body-worn devices that doesn’t involve any motors, pulleys, or gears. (Read more...)

Acucela Initiates Phase 2a Study of Emixustat Hydrochloride Addressing Patients with Stargardt Disease

SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596) committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide, announced today that on January 25, 2017, the first patient has enrolled in a study to evaluate Acucela’s leading drug candidate, emixustat hydrochloride (“emixustat”) in subje

Presbia Announces Price and Key Dates Related to Rights Offering

DUBLIN–(BUSINESS WIRE)–Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announces the key dates relative to its rights offering. Shareholders are advised to ensure they own Presbia’s ordinary shares as of 5 PM ET on February 1, 2017 to be considered a shareholder of record on February 6, 2017. Shareholders are advised to direct all questions and informational requests to the contacts listed below. Under the rights offering, Presbia plans to distr